Adverse Events in Connective Tissue Disease–Associated Pulmonary Arterial Hypertension

Abstract

Patients with CTD-associated PAH experienced more treatment-related AEs compared to those with idiopathic PAH in therapeutic clinical trials. These findings suggest that the overall benefit of advanced therapies for PAH may be attenuated by the greater frequency of AEs.